You have been asked to be a peer reviewer for a team of nurse researchers who are conducting a phenomenological study of the experiences of physical abuse during pregnancy. What specific questions would you ask the team during debriefing and what documents would you want the researchers to share?

I need at least 2 references including this book:

Polit, D. F., & Beck, C. T. (2012). Nursing research: generating and assessing evidence for nursing practice (Ninth ed.). Philadelphia: Wolters Kluwer, Lippincott Williams & Wilkins.

Assignment: Practicum Experience NURS 8600

In order to ensure that you are building nursing-related skills and competencies within your practicum setting, it is important to develop specific, appropriate objectives for your practicum hours each quarter. The Practicum Experience allows you to compile your learning objectives and planned timeline for completing your practicum hours and developing your specialty area knowledge and skills. At the end of this quarter, you will use the information in your Practicum Experience to evaluate your progress and achievements in your practicum setting.

If you have previously enrolled in NURS 8600, be sure to develop unique objectives for your Practicum Experience. These may be extensions of previous objectives, or they may be completely new and original objectives intended to expand your experiences in the practicum setting. If you are experiencing difficulty formulating new objectives for your Practicum Experience, consult with your Instructor in this course for additional guidance.

To prepare:

• Think      about learning objectives that would guide your practicum hours, as well      as the activities you will undertake to achieve those objectives. Draft      three learning objectives that are related to the AACN Essentials      (see attached file), your practice area specialty competencies, and the      focus of this course.
• Refer      to the Practicum Time Log and Journal document.
• Develop      a timeline for your Practicum Experience.

To complete:

By tomorrow 8/28/19, write a 2-page paper in APA format with at least 3 scholarly references that includes the level one headers as numbered below:

1) Three learning objectives for your practicum hours that are aligned to the American Association of Colleges of Nursing (AACN) Essentials, your specialty area competencies, the focus of this course (i.e., implementation, evaluation, and dissemination of an evidence-based project), and other aspects of your professional growth and development (see attached file).

2) Activities you will undertake to fulfill your identified learning objectives

3) A proposed timeline for accomplishing your practicum hours (a total of 216 hours over 11 weeks)

P.S.  Use the template attached to complete this assignment. Also, refer to previous class learning objectives to help you write this assignment

Required Reading

Class Learning Objectives

Students will:

• Participate      in a scholarly forum with colleagues and the course Instructor
• Develop      practicum objectives aligned to the American Association of Colleges of      Nursing Essentials, professional standards, and specialty guidelines

The primary objective of your practicum is to “build and assimilate knowledge for advanced specialty practice at a high level of complexity,” (AACN, 2006, p. 19). Thus, focus on ways to expand your specialty practice knowledge at the aggregate level and consider roles you are interested in occupying after the completion of the DNP program.

American Association of Colleges of Nursing (AACN). (2006). The essentials of doctoral education for advanced nursing practice. Retrieved from http://www.aacn.nche.edu/publications/position/DNPEssentials.pdf (see attached file).

Use the information in this report to guide the formulation of goals for your practicum experience.

Su, W. M., & Osisek, P. J. (2011). The revised Bloom’s Taxonomy: Implications for educating nurses. The Journal of Continuing Education in Nursing, 42(7), 321-327. (See attached file)

Bleich, M. R. (2011). IOM report, The Future of Nursing: Leading Change, Advancing Health: milestones and challenges in expanding nursing science. Research in Nursing & Health, 34(3), 169-170. doi:10.1002/nur.20433 (see attached file)

IOM report, The Future of Nursing: Leading Change, Advancing Health: milestones and challenges in expanding nursing science. Research in Nursing & Health by Bleich, M. R., in Research in Nursing & Health, Vol. 34/Issue 3. Copyright 2011 by John Wiley & Sons – Journals. Reprinted by permission of John Wiley & Sons – Journals via the Copyright Clearance Center.

Pritham, U. P. (2016). Assessing DNP impact using program evaluations to capture healthcare system change. The Nurse Practitioner, (4), 44.

Kotter, J. P. (2007). Leading change: Why transformation efforts fail. Harvard Business Review, 85(1), 96-103. Retrieved from https://cb.hbsp.harvard.edu/cbmp/pl/76758028/76758030/42e82c2469b7f33387aa79dc5736bb1f

In this foundational reading, Dr. John Kotter discusses errors commonly made as organizations undergo change, and he recommends steps leaders can take to help avoid them (see attached file).

Moriber, N. A., Wallace-Kazer, M., Shea, J., Grossman, S., Wheeler, K., & Conelius, J. (2014). Transforming Doctoral Education Through the Clinical Electronic Portfolio. Nurse Educator, 39(5), 221-226. doi:10.1097/NNE.0000000000000053

Murphy, M. P., Staffileno, B. A., & Carlson, E. (2015). Original Article: Collaboration Among DNP- and PhD-Prepared Nurses: Opportunity to Drive Positive Change. Journal of Professional Nursing,31388-394. doi: 10.1016/j.profnurs.2015.03.001

Sherrod, B., & Goda, T. (2016). DNP-Prepared leaders guide healthcare system change. Nursing Management, (9). 13.

Antimicrobial agents are essential components in the treatment of various bacterial infections as they help to kill or prevent the growth of microbes such as bacteria, fungi, and protozoans. Prior to the discovery of antimicrobial agents, treatment options for patients with bacterial infections were limited. For many patients, treatment often resulted in the amputation of limbs or even death. Today, treatment options for bacterial infections typically have a more positive prognosis. Due to the various types of infections presented in patients, it is essential to be able to identify the underlying cause of the infection—whether bacterial or viral—before recommending drug treatments. This will help you identify whether or not an antimicrobial agent would be appropriate and which specific agent would target the infection. In this Assignment, you consider the appropriate use of antimicrobial agents for infections.

To prepare:

• – Review this week’s media presentation      on principles of antimicrobial therapy, as well as Chapter 8 of the      Arcangelo and Peterson text.
• – Consider the categories of      antimicrobial agents.
• – Think about differences between viral      and bacterial infections.
• – Reflect on why proper identification      of the infection is key to selecting the proper antimicrobial agent.

POST a 2- to 3- page paper that addresses the following:

• – Describe the categories of      antimicrobial agents.
• – Describe differences between viral      and bacterial infections.
• – Explain why proper identification of      viral and bacterial infections is key to selecting the proper      antimicrobial agent.

This work should have Introduction and conclusion

– This work should have at 4 to 6 current references (Year 2012 and up)

– Use at least 3 references from class Learning Resources

The following Resources are not acceptable:

1. Wikipedia

2. Cdc.gov- nonhealthcare professionals section

3. Webmd.com

4. Mayoclinic.com

Required Readings

Arcangelo, V. P., Peterson, A. M., Wilbur, V., & Reinhold, J. A. (Eds.). (2017). Pharmacotherapeutics for advanced practice: A practical approach (4th ed.). Ambler, PA: Lippincott Williams & Wilkins.

• Chapter 8, “Principles of      Antimicrobial Therapy” (pp. 111-134)
  This chapter covers factors that impact the selection of an antimicrobial      treatment regimen. It also examines the clinical uses, adverse events, and      drug interactions of various antimicrobial agents such as penicillin.
• Chapter 12, “Fungal Infections      of the Skin” (pp. 163-196)
  This chapter explores the pathophysiology of several fungal infections of      the skin as well as related drug treatments and examines the importance of      patient education when managing these infections.
• Chapter 14, “Bacterial      Infections of the Skin” (pp. 181-196)
  This chapter begins by examining causes of bacterial infections. It then      explores the importance of selecting an appropriate agent for treating      bacterial infections.
• Chapter 32, “Urinary Tract      Infection” (pp. 519-526)
  This chapter covers drugs used to treat urinary tract infections and      identifies special considerations when treating geriatric patients,      pediatric patients, and women.
• Chapter 35, “Sexually      Transmitted Infections” (pp. 512-535)
  This chapter outlines the causes, pathophysiology, and drug treatment of      six sexually transmitted infections, including gonorrhea, syphilis, and      human papilloma virus infection (HPV). It also examines the importance of      selecting the proper agent and monitoring patient response to treatment.
• Chapter 49, “Human Immunodeficiency Virus” (pp.      843-860)
  This chapter presents the causes, pathophysiology, diagnostic criteria,      and prevention methods for HIV. It also covers various methods of drug      treatment and patient factors to consider when selecting, administering,      and managing drug treatments.

Krummenacher, I., Cavassini, M., Bugnon, O., & Schneider, M. (2011). An interdisciplinary HIV-adherence program combining motivational interviewing and electronic antiretroviral drug monitoring. AIDS Care, 23(5), 550–561.

This article analyzes medication adherence in HIV patients and examines factors that increase adherence as well as factors that contribute to termination or discontinuation of treatment.

Drugs.com. (2012). Retrieved from http://www.drugs.com/

This website presents a comprehensive review of prescription and over-the-counter drugs including information on common uses and potential side effects. It also provides updates relating to new drugs on the market, support from health professionals, and a drug-drug interactions checker.

Scourfield, A., Waters, L., & Nelson, M. (2011). Drug combinations for HIV: What’s new? Expert Review of Anti-Infective Therapy, 9(11), 1001–1011.

Note: Retrieved from the Walden Library databases.

This article examines current therapies and strategies for treating HIV patients. It also examines factors that impact selection of therapy, including drug interactions, personalization of therapy, costs, management of comorbidities, and patient response.

Required Media

Laureate Education, Inc. (Executive Producer). (2012). Antimicrobials. Baltimore, MD: Author.

This media presentation outlines principles of antimicrobial therapy 

Note: The approximate length of this media piece is 7 minutes.

Mayer, K. H., & Krakower, D. (2012). Antiretroviral medication and HIV prevention: New steps forward and New Questions. Annals of Internal Medicine, 156(4), 312–314.

Instruction:

Please look at the American Academy of Gastroenterology Clinical Guidelines for the updated H.Pylori therapy. This is the website and you may copy it and paste it in the internet to get the article journal with the treatment guidelines:

http://gi.org/wp-content/uploads/2017/02/ACGManagementofHpyloriGuideline2017.pdf

This is an example

GI Case Study: H. Pylori infection

Questions: American Academy of Gastroenterology Clinical Guidelines

According to the ACC/AHA Guidelines, what medication should this patient be prescribed? Write her complete prescriptions using the prescription writing format.

ACC/AHA Guidelines

Chief complaint: “ I have recurrent H. Pylori infection”.

HPI: M.C. a 46-year-old hispanic female presents to the GI clinic for complaint of recurrent H. Pylori infection. She was treated about 2 ½ months ago with H. Pylori triple therapy and failed treatment. She has pmhx of dyspepsia, GERD.

She also indicates that she has noticed that her symptoms of dyspepsia are worsening for past 2 months. She has associated her symptoms with nausea, upset stomach with all foods.

Denies associated symptoms of hematochezia, melena, hemoptysis, abdominal pain, fever, chills, pain or any other symptoms.

PMH:

H. Pylori infection gastritis

Diabetes Mellitus, type 2

Surgeries: None

Allergies: NKDA

Vaccination History:

She receives an annual flu shot. Last flu shot was this year

Social history:

High school graduate, married and no children. He frequently eats out in restaurants. He drinks one 4-ounce glass of red wine daily. He is a former smoker that stopped 3 years ago.

Family history:

Both parents are alive. Father has history of DM type 2, Tinea Pedis.

mother alive and has history of atopic dermatitis, tinea corporis and tinea pedis.

ROS:

Constitutional: Negative for fever. Negative for chills.

Respiratory: No Shortness of breath. No Orthopnea

Cardiovascular: No edema. No palpitations.

Gastrointestinal: No vomiting. +Dyspepsia. + Nausea. No constipation. No melena. No abdominal pain.

Skin: No lesions. No rash. No itching.

Psychiatric: No anxiety. No depression.

Physical examination:

Vital Signs

Height: 5 feet 5 inches Weight: 140 pounds BMI: 31 obesity, BP 110/70 T 98.0 po P 80 R 22, non-labored

HEENT: Normocephalic/Atraumatic, PERRL, EOMI; No teeth loss seen. Gums no redness.

NECK: Neck supple, no palpable masses, no lymphadenopathy, no thyroid enlargement.

LUNGS: Lungs clear bilaterally. Equal breath sounds. Symmetrical respiration. No respiratory distress.

HEART: Normal S1 with S2 during expiration. Pulses are 2+ in upper extremities. No edema.

ABDOMEN: No abdominal distention. Nontender. Bowel sounds + x 4 quadrants. No organomegaly. Normal contour; No palpable masses.

GENITOURINARY: No CVA tenderness bilaterally. GU exam deferred.

MUSCULOSKELETAL: Slow gait but steady. No Kyphosis.

SKIN: Dry. Intact.

PSYCH: Normal affect. Cooperative.

Labs day of visit:: Hgb 15.2, Hct 40%, K+ 4.0, Na+137, Serum Creatinine normal 1.0, AST/ALT normal. TSH 3.7 normal, glucose 98 normal

A:

Primary Diagnosis: Recurrent H. Pylori infection gastritis

Secondary Diagnoses:

Dyspepsia

Differential Diagnosis:

Peptic Ulcer Disease

Previous medication plan: two months ago and failed.

Clarithromycin 500 mg po BID for 2 weeks
Omeprazole 40 mg po BID for 2 weeks and then po daily.
Cipro 500 mg po BID for 2 weeks
Plan: Tests

Pt had EGD done 2 weeks ago that showed H. Pylori positive gastritis in biopsy results.

Urea breath test 8 weeks after treat with H. Pylori medications. Pt needs to stop PPI’s 2 weeks prior to Urea Breath test.

Labs: No new labs are needed.

Referrals: may refer based on effect of medication therapy given for 2 weeks.

Follow up: return to office in 8 weeks to reevaluate her symptoms.